Overactive Bladder
📧 Sign up to get email alerts when something new happens for Overactive Bladder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: Different Injection Number of the Same Dose of Botulinum Toxin A on Overactive Bladder Syndrome [Phase 2]
A Phase 2 trial evaluating different numbers of injections at the same dose of Botulinum toxin A for overactive bladder has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: Injections of Botulinum Toxin A in Treatment of Patients With Detrusor Overactivity and Impaired Contractility [Phase 2]
Phase 2 clinical trial evaluating injections of Botulinum toxin type A for detrusor overactivity with impaired contractility; study complete…
-
CLINICAL_TRIALS trial_result · 2017-02-14Clinical Trial Update: A Study to Evaluate Tolerability and Participants Preference Between Mirabegron and Tolterodine Extended Release (ER) in Participants With Overactive Bladder (OAB) [Phase 4]
Phase 4 trial comparing tolerability and patient preference between mirabegron and tolterodine ER in adults with overactive bladder has comp…
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: Therapeutic Efficacy and Safety of Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan [Phase 3]
Phase 3 clinical trial update assessing the efficacy and safety of mirabegron for overactive bladder in Taiwan.
-
CLINICAL_TRIALS research · 2017-02-03Clinical Trial Update: Linkage Analysis in Interstitial Cystitis
This is a completed clinical trial update describing linkage analysis in interstitial cystitis and related urological conditions.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-01-30Clinical Trial Update: A Study to Investigate How Effective and Safe Solifenacin Succinate Suspension is in Treating Children/Adolescents Aged 5 to Less Than 18 Years With Symptoms of Overactive Bladder (OAB) Compared to a Non-active Drug [Phase 3]
A Phase 3 study evaluating the effectiveness and safety of solifenacin succinate suspension for treating overactive bladder in children aged…
-
FDA approval · 2017-01-26FDA Approved: TOVIAZ — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for TOVIAZ (fesoterodine fumarate) submitted by Pfizer Laboratories Div Pfizer Inc.
-
CLINICAL_TRIALS trial_result · 2017-01-20Clinical Trial Update: A Study Of GW679769 Compared To Placebo In Women With Overactive Bladder [Phase 2]
GlaxoSmithKline completed a Phase 2 trial comparing GW679769 to placebo in women with overactive bladder. The update indicates the trial is …
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Clinical Study to Assess the Efficacy and Safety of THVD-201 in Patients With OAB [Phase 3]
Phase 3 clinical trial updating the efficacy and safety of THVD-201 in patients with overactive bladder has been completed.
-
FDA approval · 2017-01-05FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Accord Healthcare, Inc.)
FDA approved a supplemental application for Accord Healthcare, Inc. to market oxybutynin chloride as a generic product.
-
CLINICAL_TRIALS trial_result · 2017-01-04Clinical Trial Update: IVES for Treatment of UUI and OAB [EARLY_Phase 1]
This entry reports the completion of a Phase 1 trial evaluating the drug IVES for overactive bladder and urinary urge incontinence.
-
CLINICAL_TRIALS trial_result · 2017-01-02Clinical Trial Update: Efficacy and Safety of Gabapentin in Treating Overactive Bladder [Phase 2, Phase 3]
Gabapentin for overactive bladder has completed Phase 2 and Phase 3 trials assessing efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Utilization of the BIOWAVE Device to Treat Overactive Bladder [NA]
Completed clinical trial update for the BIOWAVE device in the treatment of overactive bladder. Results were posted in December 2016.
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Low-level Light Therapy for Overactive Bladder and Urinary Incontinence [Phase 3]
Phase 3 clinical trial update on low-level light therapy for overactive bladder and urinary incontinence; current status is unknown.
-
CLINICAL_TRIALS withdrawal · 2016-12-06Clinical Trial Update: Solifenacin Succinate Versus Placebo in Inner City Women Ages 20-45 With Overactive Bladder [Phase 4]
A Phase 4 clinical trial of solifenacin succinate vs placebo in inner-city women with overactive bladder was withdrawn.
-
FDA approval · 2016-11-22FDA Approved: TOLTERODINE TARTRATE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved an Abbreviated New Drug Application for tolterodine tartrate by Teva Pharmaceuticals USA, enabling a generic version for overac…
-
CLINICAL_TRIALS trial_result · 2016-11-21Clinical Trial Update: Preoperative Use of Darifenacin (Enablex) to Alleviate Postoperative Ureteral Stent Pain [NA]
A terminated clinical trial evaluated preoperative use of darifenacin (Enablex) to alleviate postoperative ureteral stent pain, with results…
-
FDA approval · 2016-11-17FDA Approved: DARIFENACIN — Original Application (Torrent Pharmaceuticals Limited)
FDA approved the original ANDA for Darifenacin from Torrent Pharmaceuticals Limited. Darifenacin is used to treat overactive bladder, includ…
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: Long-Term Specified Drug Use-results Survey of Betanis Tablets
This completed long-term study provides results from a specified-use survey of Betanis tablets for overactive bladder, focusing on safety an…
-
CLINICAL_TRIALS research · 2016-10-27Clinical Trial Update: A Study to Compare the Efficacy and Safety of Ultrasound Guided Lead Implantation for Sacral Neuromodulation (SNM) in Subjects With Overactive Bladder (OAB) With X-Ray Guided Technique [Phase 1]
This Phase 1 study compares ultrasound-guided lead implantation for sacral neuromodulation versus X-ray guidance in adults with refractory o…
-
CLINICAL_TRIALS research · 2016-10-24Clinical Trial Update: Do Patient Anxiety Levels Decrease Urodynamic Test Reproducibility?
A completed clinical trial investigated whether patient anxiety levels influence the reproducibility of urodynamic testing in people with ov…
-
CLINICAL_TRIALS trial_result · 2016-10-24Clinical Trial Update: Observational Study of Botulinum Toxin Type A in Patients With Urinary Incontinence Associated With Overactive Bladder
An observational study evaluating botulinum toxin type A for urinary incontinence due to overactive bladder (including neurogenic bladder) h…
-
CLINICAL_TRIALS trial_result · 2016-10-20Clinical Trial Update: Safety and Pharmacokinetic Characteristics After Administration of HIP1503 and HGP1103 in Healthy Male Volunteers [Phase 1]
Phase 1 trial in healthy male volunteers assessing safety and pharmacokinetics of two investigational agents, HIP1503 and HGP1103, with Over…
-
CLINICAL_TRIALS trial_result · 2016-10-20Clinical Trial Update: Use of Transcutaneous Posterior Tibial Nerve Stimulation (TPTNS) in Maintaining OAB Symptoms Improvement. [NA]
This document provides an update on a completed trial evaluating whether transcutaneous posterior tibial nerve stimulation can maintain impr…
-
CLINICAL_TRIALS trial_result · 2016-10-17Clinical Trial Update: A Study of the Effect of Antibiotics on the Microbiology of the Bladder in Patients With Overactive Bladder
This clinical trial update reports the completion of a study examining the effect of antibiotics on the bladder microbiology of patients wit…